The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2017 | What do current multiple myeloma clinical trials have in common?
Xavier Leleu, MD, PhD, from the Poitiers University Hospital, Poitiers, France, gives an overview of current clinical trials in multiple myeloma at the 2017 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France. He explains that the majority of clinical trials are assessing different combination therapies, either as induction, consolidation or maintenance therapy. Dr Leleu also speaks about response-adjusted clinical trials, where dosage is adjusted depending on depth of response.
